| Year |
Citation |
Score |
| 2017 |
Kameyama M, Ishibashi K, Sakurai K, Toyohara J, Wagatsuma K, Sakata M, Kameyama YU, Shimoji K, Tago T, Kanemaru K, Murayama S, Tokumaru AM, Ishii K. [P4–501]: VOXEL‐BASED MORPHOMETRY (VBM) FOCUSING ON MEDIAL TEMPORAL LOBE ATROPHY HAS LIMITED CAPABILITY IN DETECTING AMYLOID BETA Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.07.663 |
0.416 |
|
| 2013 |
Kanemaru K, Kanemaru A, Murayama S. P2-067: CSF SAPPβ, beta-amyloid 42, tau and p-tau levels in alzheimer's disease and dementia with Lewy bodies Alzheimer's & Dementia. 9: P367-P367. DOI: 10.1016/j.jalz.2013.05.710 |
0.332 |
|
| 2009 |
Ishii K, Ishiwata K, Oda K, Sakata M, Ishikawa M, Ishibashi K, Saito Y, Tokumaru A, Kanemaru K, Murayama S. IC-P-057: Differential effect of APOE 4 allele on Amyloid beta accumulation in Alzheimer's disease and non-Alzheimer's disease Alzheimer's & Dementia. 5: P27-P27. DOI: 10.1016/J.Jalz.2009.05.611 |
0.327 |
|
| 2009 |
Ishii K, Ishiwata K, Oda K, Sakata M, Ishikawa M, Ishibashi K, Saito Y, Tokumaru A, Kanemaru K, Murayama S. P3-090: Differential effect of APOE 4 allele on Amyloid beta accumulation in AD and non-AD Alzheimer's & Dementia. 5: P369-P369. DOI: 10.1016/J.Jalz.2009.04.1166 |
0.362 |
|
| 2000 |
Kanemaru K, Kameda N, Yamanouchi H. Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology. 54: 1875-6. PMID 10802808 DOI: 10.1212/WNL.54.9.1875 |
0.388 |
|
| 1996 |
Kanemaru K, Meckelein B, Marshall DC, Sipe JD, Abraham CR. Synthesis and secretion of active alpha 1-antichymotrypsin by murine primary astrocytes. Neurobiology of Aging. 17: 767-71. PMID 8892350 DOI: 10.1016/0197-4580(96)00111-X |
0.556 |
|
| 1996 |
Kanemaru K, Iwatsubo T, Ihara Y. Comparable amyloid beta-protein (A beta) 42(43) and A beta 40 deposition in the aged monkey brain. Neuroscience Letters. 214: 196-8. PMID 8878117 DOI: 10.1016/0304-3940(96)12893-7 |
0.549 |
|
| 1993 |
Abraham CR, Kanemaru K, Mucke L. Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. Brain Research. 621: 222-32. PMID 8242336 DOI: 10.1016/0006-8993(93)90110-9 |
0.502 |
|
| 1992 |
Abraham CR, Razzaboni BL, Papastoitsis G, Picard E, Kanemaru K, Meckelein B, Mucke L. Purification and cloning of brain proteases capable of degrading the beta-amyloid precursor protein. Annals of the New York Academy of Sciences. 674: 174-9. PMID 1288362 DOI: 10.1111/J.1749-6632.1992.Tb27486.X |
0.301 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Kurihara M, Komatsu H, Sengoku R, Shibukawa M, Morimoto S, Matsubara T, Arakawa A, Orita M, Ishibashi K, Mitsutake A, Shibata S, Ishiura H, Adachi K, Ohse K, Hatano K, ... ... Kanemaru K, et al. CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease. Neurology. PMID 36517236 DOI: 10.1212/WNL.0000000000201647 |
0.29 |
|
| 2006 |
Tagami S, Tsujimoto Y, Akaike A, Takashima A, Hasegawa M, Ishiguro K, Shoji M, Ito N, Kanemaru K, Urakami K, Okochi M, Takeda M. Involvement of apoptosis and cholinergic dysfunction in Alzheimer's disease Psychogeriatrics. 6: S57-S63. DOI: 10.1111/J.1479-8301.2006.00172.X |
0.289 |
|
| 2017 |
Morimoto S, Takao M, Hatsuta H, Nishina Y, Komiya T, Sengoku R, Nakano Y, Uchino A, Sumikura H, Saito Y, Kanemaru K, Murayama S. Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study. Plos One. 12: e0171524. PMID 28166276 DOI: 10.1371/Journal.Pone.0171524 |
0.263 |
|
| 2013 |
Kanemaru K. [Immunotherapy targeting misfolded proteins in neurodegenerative disease]. Brain and Nerve = Shinkei Kenkyu No Shinpo. 65: 469-74. PMID 23568995 |
0.26 |
|
| 2017 |
Kanemaru K, Kanemaru A, Murayama S, Tokumaru AM. [P2-213]: RELATIONSHIP BETWEEN CEREBRAL AMYLOID ANGIOPATHY AND CSF BIOMARKERS IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P692-P692. DOI: 10.1016/j.jalz.2017.06.865 |
0.241 |
|
| 2017 |
Kanemaru K, Sengoku R, Nishina Y, Murayama S. Relationship between cerebral amyloid angiopathy and CSF biomarkers in Alzheimer’s disease Journal of the Neurological Sciences. 381: 667. DOI: 10.1016/j.jns.2017.08.1877 |
0.237 |
|
| 2008 |
Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. Journal of Neuropathology and Experimental Neurology. 67: 1072-83. PMID 18957894 DOI: 10.1097/Nen.0B013E31818B4126 |
0.216 |
|
| 2006 |
Kanemaru K, Kanemaru A, Mutayama S, Tokumaru AM. P2‐232: RELATIONSHIP BETWEEN CEREBRAL AMYLOID ANGIOPATHY AND CSF BIOMARKERS IN DEMENTIA WITH LEWY BODIES Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.06.919 |
0.214 |
|
| 2017 |
Murayama S, Sengoku R, Kanemaru K, Nishina Y, Takada T, Kobayashi M, Yamazaki M, Saito Y. The brain bank for aging research project, Tokyo, Japan Journal of the Neurological Sciences. 381: 845. DOI: 10.1016/J.Jns.2017.08.2379 |
0.209 |
|
| 2020 |
Kameyama M, Ishibashi K, Toyohara J, Wagatsuma K, Umeda-Kameyama Y, Shimoji K, Kanemaru K, Murayama S, Ogawa S, Tokumaru AM, Ishii K. Voxel-based morphometry focusing on medial temporal lobe structures has a limited capability to detect amyloid β, an Alzheimer's disease pathology. Aging. 12. PMID 33024054 DOI: 10.18632/aging.104012 |
0.208 |
|
| 2015 |
Hatsuta H, Takao M, Ishii K, Ishiwata K, Saito Y, Kanemaru K, Arai T, Suhara T, Shimada H, Shinotoh H, Tamaoka A, Murayama S. Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology. Current Alzheimer Research. 12: 278-86. PMID 25731622 DOI: 10.2174/1567205012666150302155930 |
0.203 |
|
| 2017 |
Araki W, Hattori K, Kanemaru K, Yokoi Y, Omachi Y, Takano H, Sakata M, Yoshida S, Tsukamoto T, Murata M, Saito Y, Kunugi H, Goto YI, Nagaoka U, Nagao M, et al. Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders. Biomarker Research. 5: 28. PMID 29018524 DOI: 10.1186/S40364-017-0108-5 |
0.202 |
|
| 2010 |
Murayama S, Saito Y, Hatsuta H, Adachi T, Funabe S, Sugiyama M, Ishii K, Kanemaru K, Tokumaru A. P1-211: The Brain Bank for Aging Research Project, Tokyo, Japan Alzheimer's & Dementia. 6: S235-S235. DOI: 10.1016/J.Jalz.2010.05.762 |
0.199 |
|
| 2021 |
Araki W, Kanemaru K, Hattori K, Tsukamoto T, Saito Y, Yoshida S, Takano H, Sakata M, Yokoi Y, Omachi Y, Nagaoka U, Nagao M, Komori T, Tachimori H, Murayama S, et al. Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment. Aging Clinical and Experimental Research. PMID 34283410 DOI: 10.1007/s40520-021-01935-7 |
0.181 |
|
| 2020 |
Kanemaru K, Kanemaru A, Murayama S. Relationship between cerebral amyloid angiopathy and plasma homocysteine levels in Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.042109 |
0.179 |
|
| 2021 |
Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, ... ... Kanemaru K, et al. Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations. Bmj Open. 11: e051343. PMID 34193504 DOI: 10.1136/bmjopen-2021-051343 |
0.173 |
|
| 2011 |
Morimoto S, Kanemaru K, Takao M, Hatsuta H, Funabe S, Saito Y, Murayama S. P2-051: CSF biomarker is useful for differential diagnosis of Alzheimer disease (AD) and dementia with Lewy bodies (DLB); An autopsy- confirmed study Alzheimer's & Dementia. 7: S323-S324. DOI: 10.1016/J.Jalz.2011.05.940 |
0.169 |
|
| 2002 |
Shoji M, Matsubara E, Murakami T, Manabe Y, Abe K, Kanai M, Ikeda M, Tomidokoro Y, Shizuka M, Watanabe M, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, ... ... Kanemaru K, et al. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiology of Aging. 23: 363-70. PMID 11959397 DOI: 10.1016/S0197-4580(01)00309-8 |
0.169 |
|
| 1996 |
Kanemaru K, Yamanouchi H. [Cerebrospinal fluid tau in senile dementia of Alzheimer type]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 32: 597-8. PMID 8531407 DOI: 10.3143/GERIATRICS.32.597 |
0.165 |
|
| 2016 |
Kaneda D, Sengoku R, Kanemaru K, Morimoto S, Nishina Y, Fujigasaki J, Tokumaru A, Ishii K, Saito Y, Murayama S. P1-347: The Establishment of The Biobank for Aging Research in Liaison with The Brain Bank for Aging Research, Tokyo, Japan Alzheimer's & Dementia. 12: P562-P562. DOI: 10.1016/J.Jalz.2016.06.1098 |
0.163 |
|
| 2019 |
Kanemaru K, Kanemaru A, Murayama S. P2-224: DECREASED LEVELS OF CSF ABETA40 IN DEMENTIA WITH LEWY BODIES Alzheimer's & Dementia. 15: P663-P664. DOI: 10.1016/j.jalz.2019.06.2631 |
0.16 |
|
| 2004 |
Kanemaru K, Murayama S, Saitoh Y, Yamanouchi H. P3-050 Correlation of CSF biomarkers with Alzheimer pathology Neurobiology of Aging. 25: S365. DOI: 10.1016/S0197-4580(04)81203-X |
0.156 |
|
| 2005 |
Murayama S, Saito Y, Kanemaru K, Tokumaru A, Ishii K, Sawabe M. [Establishment of brain bank for aging research]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 42: 483-9. PMID 16248404 DOI: 10.3143/Geriatrics.42.483 |
0.152 |
|
| 2017 |
Nakano Y, Takahashi-Fujigasaki J, Sengoku R, Kanemaru K, Arai T, Kanda T, Murayama S. PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease. Journal of Neuropathology and Experimental Neurology. 76: 585-594. PMID 28863453 DOI: 10.1093/jnen/nlx039 |
0.143 |
|
| 2007 |
Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Mizusawa H, Murayama S. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease. Journal of Neuropathology and Experimental Neurology. 66: 354-62. PMID 17483692 DOI: 10.1097/Nen.0B013E3180517454 |
0.138 |
|
| 2014 |
Kanemaru K, Kanemaru A, Murayama S. P1-139: ASSESSMENT OF CSF A-SYNUCLEIN LEVELS DISTINGUISHES DEMENTIA WITH LEWY BODIES FROM ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P350-P350. DOI: 10.1016/j.jalz.2014.05.376 |
0.138 |
|
| 2002 |
Kanemaru K, Yamanouchi H. Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer's disease. Journal of Neurology. 249: 1125-6. PMID 12420719 DOI: 10.1007/s00415-002-0753-x |
0.133 |
|
| 2010 |
Ishibashi K, Kanemaru K, Saito Y, Murayama S, Oda K, Ishiwata K, Mizusawa H, Ishii K. Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease. Acta Neurologica Scandinavica. 122: 46-51. PMID 20002007 DOI: 10.1111/J.1600-0404.2009.01255.X |
0.131 |
|
| 2012 |
Kanemaru K, Kanemaru A, Murayama S. P1-032: sAPPβ levels in Alzheimer's disease and dementia with Lewy bodies Alzheimer's & Dementia. 8: P118-P118. DOI: 10.1016/j.jalz.2012.05.307 |
0.13 |
|
| 2015 |
Morimoto S, Takao M, Sakurai K, Sunagawa M, Komiya T, Arai T, Kanemaru K, Murayama S. Steroid responsive chronic meningoencephalitis reminiscent of rheumatoid meningitis: a case report. Rinsho Shinkeigaku = Clinical Neurology. PMID 26084231 DOI: 10.5692/clinicalneurol.cn-000720 |
0.129 |
|
| 2008 |
Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S. Lewy body pathology involves cutaneous nerves. Journal of Neuropathology and Experimental Neurology. 67: 945-53. PMID 18800013 DOI: 10.1097/Nen.0B013E318186De48 |
0.126 |
|
| 2004 |
Murayama S, Saito Y, Ishii K, Mitani K, Kanemaru K, Yamanouchi H, Kurisaki H, Imafuku I. [Parkinson disease with dementia--responsible locus for dementia]. Rinsho Shinkeigaku = Clinical Neurology. 44: 824-6. PMID 15651303 |
0.125 |
|
| 2014 |
Sakurai K, Tokumaru AM, Nakatsuka T, Murayama S, Hasebe S, Imabayashi E, Kanemaru K, Takao M, Hatsuta H, Ishii K, Saito Y, Shibamoto Y, Matsukawa N, Chikui E, Terada H. Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition. Insights Into Imaging. 5: 375-85. PMID 24519790 DOI: 10.1007/S13244-014-0312-X |
0.125 |
|
| 2019 |
Hatsuta H, Takao M, Nogami A, Uchino A, Sumikura H, Takata T, Morimoto S, Kanemaru K, Adachi T, Arai T, Hasegawa M, Murayama S. Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage. Acta Neuropathologica Communications. 7: 49. PMID 30922392 DOI: 10.1186/s40478-019-0700-z |
0.124 |
|
| 2008 |
Ishii K, Ishiwata K, Oda K, Kimura Y, Sakata M, Kawasaki K, Hashimoto M, Ishikawa M, Ishibashi K, Nishina Y, Saito Y, Tokumaru A, Kanemaru K, Murayama S. IC-P1-030: Does Amyloid β accumulation modify clinical feature of frontotemporal dementia? Alzheimer's & Dementia. 4: T20-T21. DOI: 10.1016/J.Jalz.2008.05.041 |
0.124 |
|
| 2006 |
Ishii K, Kawasaki K, Saito Y, Oda K, Kimura Y, Ishiwata K, Saito Y, Tokumaru A, Mitani K, Kanemaru K, Murayama S. P2-319: FDG-PET images in pathologically confirmed Alzheimer's disease and dementia with lewy bodies: Implications for early differential diagnosis Alzheimer's & Dementia. 2: S334-S335. DOI: 10.1016/J.Jalz.2006.05.1159 |
0.122 |
|
| 2024 |
Kurihara M, Matsubara T, Morimoto S, Arakawa A, Ohse K, Kanemaru K, Iwata A, Murayama S, Saito Y. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases. Acta Neuropathologica Communications. 12: 48. PMID 38539238 DOI: 10.1186/s40478-024-01758-3 |
0.12 |
|
| 2004 |
MATSUDA K, TAKEDA M, URAKAMI K, HASEGAWA M, ISHIGURO K, SAIDO TC, SHOJI M, KANEMARU K, TAMAOKA A, IWATSUBO T, OKAMURA N, ITO N. Discussions on laminin as possible biomarkers for neurodegenerative dementia Psychogeriatrics. 4: S39-S44. DOI: 10.1111/j.1479-8301.2003.00030.x |
0.116 |
|
| 2016 |
Kanemaru K, Kanemaru A, Murayama S. P2-138: Association between Renal Functions and CSF Biomarkers in Alzheimer's Disease Alzheimer's & Dementia. 12: P665-P665. DOI: 10.1016/j.jalz.2016.06.1508 |
0.116 |
|
| 2019 |
Imai M, Tanaka M, Sakata M, Wagatsuma K, Tago T, Toyohara J, Sengoku R, Nishina Y, Kanemaru K, Ishibashi K, Murayama S, Ishii K. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 31771066 DOI: 10.3233/JAD-190843 |
0.113 |
|
| 2023 |
Kurihara M, Ishibashi K, Matsubara T, Hatano K, Ihara R, Higashihara M, Kameyama M, Tokumaru AM, Takeda K, Nishina Y, Kanemaru K, Ishii K, Iwata A. High sensitivity of asymmetric F-THK5351 PET abnormality in patients with corticobasal syndrome. Scientific Reports. 13: 12147. PMID 37500734 DOI: 10.1038/s41598-023-39227-x |
0.11 |
|
| 2011 |
Kanemaru K, Kanemaru A, Ishii K. P3‐438: Activation of frontal lobe by music therapy in mild cognitive impairment and Alzheimer's disease revealed by FDG‐PET Alzheimer's & Dementia. 7. DOI: 10.1016/j.jalz.2011.05.1882 |
0.106 |
|
| 2013 |
Funabe S, Takao M, Saito Y, Hatsuta H, Sugiyama M, Ito S, Kanemaru K, Sawabe M, Arai T, Mochizuki H, Hattori N, Murayama S. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 33: 47-58. PMID 22672612 DOI: 10.1111/J.1440-1789.2012.01329.X |
0.103 |
|
| 2015 |
Kanemaru K, Kanemaru A, Murayama S. P2-064: Cognitive impairment in lewy body disease is correlated with levels of CSF Aβ42 Alzheimer's & Dementia. 11: P507-P507. DOI: 10.1016/j.jalz.2015.06.601 |
0.099 |
|
| 1992 |
Kanemaru K, Takio K, Miura R, Titani K, Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. Journal of Neurochemistry. 58: 1667-75. PMID 1560225 DOI: 10.1111/j.1471-4159.1992.tb10039.x |
0.096 |
|
| 2010 |
Kanemaru K, Kanemaru A, Nishina Y, Komiya T, Murayama S. P3-185: CSF biomarkers in autopsy-confirmed dementia with Lewy bodies Alzheimer's & Dementia. 6: S505-S505. DOI: 10.1016/j.jalz.2010.05.1683 |
0.094 |
|
| 2010 |
Adachi T, Saito Y, Hatsuta H, Funabe S, Tokumaru AM, Ishii K, Arai T, Sawabe M, Kanemaru K, Miyashita A, Kuwano R, Nakashima K, Murayama S. Neuropathological asymmetry in argyrophilic grain disease. Journal of Neuropathology and Experimental Neurology. 69: 737-44. PMID 20535032 DOI: 10.1097/Nen.0B013E3181E5Ae5C |
0.092 |
|
| 2009 |
Kanemaru K, Kanemau A, Nishina Y, Komiya T, Murayama S. P3-008: Increased levels of CSF tau and phosphorylated tau (p-tau 181) correlate with memory deficits in mild cognitive impairment Alzheimer's & Dementia. 5: P343-P343. DOI: 10.1016/j.jalz.2009.04.1185 |
0.085 |
|
| 2004 |
Kazama H, Ruberu NN, Murayama S, Saito Y, Nakahara K, Kanemaru K, Nagura H, Arai T, Sawabe M, Yamanouchi H, Orimo H, Hosoi T. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tangles. Dementia and Geriatric Cognitive Disorders. 18: 145-50. PMID 15211069 DOI: 10.1159/000079194 |
0.083 |
|
| 2006 |
Kanemaru K, Kanemaru A, Ishii K, Kobayashi T, Murakami K, Akaboshi T, Akaboshi T, Endo H. P4–338: The effects of music therapy for Alzheimer's patients assessed by FDG–PET Alzheimer's & Dementia. 2. DOI: 10.1016/j.jalz.2006.05.2079 |
0.081 |
|
| 2004 |
URAKAMI K, ISHIGURO K, SAIDO TC, IWATSUBO T, OKAMURA N, ITO N, KANEMARU K, TAMAOKA A, HASEGAWA M, SHOJI M, TAKASHIMA A, HAMAMOTO M, MATSUDA K, ARAI H, TAKEDA M. Discussions on phosphorylated tau and other biochemical markers Psychogeriatrics. 4: S45-S50. DOI: 10.1111/j.1479-8301.2003.00031.x |
0.081 |
|
| 2010 |
Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, Mizusawa H, Ishii K. Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET. European Journal of Nuclear Medicine and Molecular Imaging. 37: 3-11. PMID 19626324 DOI: 10.1007/S00259-009-1202-1 |
0.078 |
|
| 2023 |
Goto R, Kurihara M, Kameyama M, Komatsu H, Higashino M, Hatano K, Ihara R, Higashihara M, Nishina Y, Matsubara T, Kanemaru K, Saito Y, Murayama S, Iwata A. Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes. Journal of Neural Transmission (Vienna, Austria : 1996). 130: 513-520. PMID 36871130 DOI: 10.1007/s00702-023-02611-y |
0.07 |
|
| 1999 |
Kanemaru K, Mitani K, Yamanouchi H. Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration. Neuroscience Letters. 245: 121-2. PMID 9605500 DOI: 10.1016/S0304-3940(98)00181-5 |
0.069 |
|
| 2008 |
Kanemaru K, Komiya T, Kanemaru A, Saito Y, Murayama S. P3-078: Prominent reduction in cerebrospinal fluid homovanillic acid and 5-hydroxyindole acetic acid levels in dementia with Lewy bodies Alzheimer's & Dementia. 4: T540-T540. DOI: 10.1016/J.Jalz.2008.05.1642 |
0.063 |
|
| 2005 |
Ishii K, Kawasaki K, Saito Y, Oda K, Ishiwata K, Saito Y, Murayama S, Mitani K, Kanemaru K, Yamanouchi H. Differentiation of early stage of Alzheimer’s disease and dementia with lewy bodies by FDG-PET Alzheimers & Dementia. 1. DOI: 10.1016/J.Jalz.2005.06.199 |
0.06 |
|
| 2001 |
Kameda N, Hattori A, Nishinaga M, Tuchimochi H, Nakahara K, Oouchi A, Matsushita T, Kanemaru K, Yamanouchi H, Orimo H. [Quantitative evaluation of the burden of those giving home care for senile dementia of Alzheimer type subjects using the burnout scale of pines]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 38: 382-7. PMID 11431895 DOI: 10.3143/geriatrics.38.382 |
0.06 |
|
| 2014 |
Ito S, Takao M, Hatsuta H, Kanemaru K, Arai T, Saito Y, Fukayama M, Murayama S. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease. International Journal of Clinical and Experimental Pathology. 7: 1714-23. PMID 24817969 |
0.059 |
|
| 2016 |
Hatsuta H, Takao M, Nakano Y, Nogami A, Uchino A, Sumikura H, Kanemaru K, Arai T, Itoh Y, Murayama S. Reduction of Small Fibers of Thoracic Ventral Roots and Neurons of Intermediolateral Nucleus in Parkinson Disease and Dementia with Lewy Bodies. Journal of Parkinson's Disease. PMID 27061071 DOI: 10.3233/JPD-150773 |
0.057 |
|
| 2017 |
Sakurai K, Tokumaru AM, Shimoji K, Murayama S, Kanemaru K, Morimoto S, Aiba I, Nakagawa M, Ozawa Y, Shimohira M, Matsukawa N, Hashizume Y, Shibamoto Y. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology. PMID 28386688 DOI: 10.1007/s00234-017-1812-4 |
0.054 |
|
| 2017 |
Kimura H, Takao M, Suzuki N, Kanemaru K, Mihara B, Murayama S. Pathologic Study of Intracranial Large Artery Atherosclerosis in 7260 Autopsy Cases. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 28756142 DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.056 |
0.052 |
|
| 2004 |
SAIDO TC, TAKEDA M, URAKAMI K, SHOJI M, ITO N, IWATSUBO T, TAMAOKA A, KANEMARU K. Discussions on role of neprilysin and degradating system Psychogeriatrics. 4: S13-S18. DOI: 10.1111/j.1479-8301.2003.00028.x |
0.051 |
|
| 2009 |
Tokumaru AM, Hasebe T, Terada H, Saito Y, Kanemaru K, Yamakawa M, Mizuno M, Murayama S. Significance of radio-pathological correlations: differentiating severe central nervous system infection from acute embolic infarction. The Neuroradiology Journal. 21: 824-9. PMID 24257052 |
0.051 |
|
| 2015 |
Sakurai K, Imabayashi E, Tokumaru AM, Hasebe S, Murayama S, Morimoto S, Kanemaru K, Takao M, Shibamoto Y, Matsukawa N. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome. Neuroimage. Clinical. 7: 605-10. PMID 26082887 DOI: 10.1016/j.nicl.2014.02.009 |
0.051 |
|
| 2006 |
Ishii K, Tago T, Ishibashi K, Wagatsuma K, Sakata M, Toyohara J, Sengoku R, Kanemaru K, Murayama S. P4-328: GLIA IMAGING WITH 18
F-THK5351 AS A POTENTIAL MARKER FOR NEURODEGENERATION Alzheimer's & Dementia. 14: P1591-P1591. DOI: 10.1016/j.jalz.2018.07.151 |
0.047 |
|
| 2015 |
Morimoto S, Kinbara Y, Terada M, Komiya T, Ishii K, Takao M, Kanemaru K, Murayama S. [A Case of Corticobasal Syndrome Complicated with Hypopituitarism and Hashimoto's Disease]. Brain and Nerve = Shinkei Kenkyū No Shinpo. 67: 759-64. PMID 26062591 DOI: 10.11477/mf.1416200213 |
0.047 |
|
| 2002 |
Kazama H, Hosoi T, Nakahara K, Murayama S, Saito Y, Kanemaru K, Nagura H, Arai T, Sawabe M, Toba K, Yamanouchi H, Orimo H. Association between a promoter polymorphism of the paraoxonase PON1
gene and pathologically verified idiopathic Parkinson’s disease Geriatrics & Gerontology International. 2: 91-96. DOI: 10.1046/J.1444-1586.2002.00030.X |
0.045 |
|
| 2018 |
Shiraishi T, Sengoku R, Takanashi S, Shibukawa M, Kanemaru K, Murayama S. [Chorea due to chronic subdural hematoma]. Rinsho Shinkeigaku = Clinical Neurology. PMID 29863098 DOI: 10.5692/clinicalneurol.cn-001102 |
0.044 |
|
| 1987 |
KANEMARU K, OOYAMA T, ODA H, KOSHIHARA Y. Effects of Collagens on Human Umbilical Vein Endothelial Cell Growth The Journal of Japan Atherosclerosis Society. 15: 803-804. DOI: 10.5551/JAT1973.15.3_803 |
0.033 |
|
| 2016 |
Morimoto S, Hatsuta H, Komiya T, Kanemaru K, Tokumaru AM, Murayama S. Simultaneous skin-nerve-muscle biopsy and abnormal mitochondrial inclusions in intranuclear hyaline inclusion body disease. Journal of the Neurological Sciences. PMID 27823834 DOI: 10.1016/j.jns.2016.10.042 |
0.028 |
|
| 2017 |
Yamazaki M, Sengoku R, Kanemaru K, Murayama S. Validation of the simple smell identification test for evaluation of olfactory dysfunction in patients with Parkinson's disease Journal of the Neurological Sciences. 381: 1050. DOI: 10.1016/j.jns.2017.08.2967 |
0.028 |
|
| 2018 |
Morimoto S, Takao M, Nishina Y, Sakurai K, Komiya T, Kanemaru K, Murayama S. Spinocerebellar ataxia type 2 presenting with rapidly progressing muscle weakness and muscular atrophy. Geriatrics & Gerontology International. 18: 361-364. PMID 29461011 DOI: 10.1111/ggi.13206 |
0.027 |
|
| 2017 |
Shibukawa M, Shibukawa M, Sengoku R, Yamazaki M, Nishina Y, Kanemaru K, Murayama S. Evaluation of orthostatic hypotension in Parkinson disease by measuring the catecholamine level and using a Cardiac MIBG scintigraphy Journal of the Neurological Sciences. 381: 920. DOI: 10.1016/j.jns.2017.08.2587 |
0.026 |
|
| 2004 |
Kanemaru K. [Mild cognitive impairment (MCI)--pathophysiology]. Nihon Rinsho. Japanese Journal of Clinical Medicine. 62: 278-81. PMID 15174685 |
0.026 |
|
| 2019 |
Kanemaru A, Kato T, Sugawara Y, Honda T, Shimizu A, Hiraoka T, Makita A, Higuchi W, Uemura H, Kawaji Y, Yamazaki R, Ota T, Kanemaru K. P2-023: THE TWELVE MONTHS’ FOLLOW-UP AFTER THE INTERVENTION USING A REHABILITATION PROGRAM OF PHYSICAL AND COGNITIVE REC-XERCISE (REPCREC) FOR THE ELDERLY WITH MILD COGNITIVE IMPAIRMENT (MCI) Alzheimer's & Dementia. 15: P579-P579. DOI: 10.1016/j.jalz.2019.06.1245 |
0.023 |
|
| 2024 |
Hatano T, Sengoku R, Nagayama H, Yanagisawa N, Yoritaka A, Suzuki K, Nishikawa N, Mukai Y, Nomura K, Yoshida N, Seki M, Matsukawa MK, Terashi H, Kimura K, Tashiro J, ... ... Kanemaru K, et al. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study. Neurology and Therapy. PMID 38227133 DOI: 10.1007/s40120-023-00574-6 |
0.02 |
|
| 2008 |
Murayama S, Saito Y, Ishii K, Kanemaru K, Tokumaru A, Matsuda H, Arima K, Shimada H, Takao M, Obi T, Ikeda M, Kurisaki H. P1-198: Biology-based approach to mild cognitive impairment Alzheimer's & Dementia. 4: T267-T267. DOI: 10.1016/J.Jalz.2008.05.786 |
0.019 |
|
| 2020 |
Kanemaru A, Kato T, Honda T, Hiraoka T, Kawaji Y, Makita A, Kuwata N, Shimizu A, Higuchi W, Sugawara Y, Uemura H, Yamazaki R, Kanemaru K. The twelve months’ follow‐up, second version, after an intervention using a rehabilitation program of physical and cognitive rec‐xercise (REPCREC) for the elderly with mild cognitive impairment (MCI) Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044195 |
0.018 |
|
| 2017 |
Kanemaru A, Kato T, Sugawara Y, Kawaji Y, Hiraoka T, Honda T, Nakajima R, Makita A, Itakura A, Yamazaki R, Ota T, Kanemaru K. [P1–095]: AN INTERVENTION STUDY OF A REHABILITATION PROGRAM USING PHYSICAL AND COGNITIVE REC‐XERCISE FOR MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 13. DOI: 10.1016/j.jalz.2017.06.162 |
0.017 |
|
| 2006 |
Kanemaru A, Kato T, Sugawara Y, Kawaji Y, Honda T, Itakura A, Hiraoka T, Makita A, Nakajima R, Yamazaki R, Ota T, Kanemaru K. P1‐044: THE SHORT‐TERM EFFECT OF THE REHABILITATION PROGRAM OF PHYSICAL AND COGNITIVE REC‐XERCISE (REPCREC) FOR THE ELDERLY WITH MILD COGNITIVE IMPAIRMENT Alzheimer's & Dementia. 14. DOI: 10.1016/j.jalz.2018.06.045 |
0.016 |
|
| 2017 |
Murayama S, Sengoku R, Shibukawa M, Kanemaru K, Sato N, Yanagisawa K. [P3-189]: ANNUAL REPORT OF BIOBANK OF AGING RESEARCH, A JOINT PROJECT OF TOKYO METROPOLITAN GERIATRIC HOSPITAL AND INSTITUTE OF GERONTOLOGY (TMGHIG) AND NATIONAL CENTER OF GERONTOLOGY AND GERIATRICS (NCGG) Alzheimer's & Dementia. 13: P1007-P1007. DOI: 10.1016/j.jalz.2017.06.1401 |
0.016 |
|
| 2016 |
Morimoto S, Tanaka J, Saito Y, Tsuyama N, Nishimura T, Komiya T, Kyo S, Arai T, Kanemaru A, Kanemaru K, Harada K. Non-bacterial thrombotic endocarditis in a Trousseau syndrome patient with stomach cancer: A case report. Geriatrics & Gerontology International. 16: 1171-1172. PMID 27758062 DOI: 10.1111/ggi.12694 |
0.013 |
|
| 2022 |
Hatano K, Nishina Y, Kanemaru K, Iwata A. Outcomes of intravenous thrombolysis for acute ischemic stroke in patients aged 90 years or older. Geriatrics & Gerontology International. PMID 36278286 DOI: 10.1111/ggi.14497 |
0.013 |
|
| 1987 |
Kanemaru K, Nagura H, Ooyama T, Tomonaga M. [Report of 6 cases with polymyalgia rheumatica and a review of the literature]. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 23: 469-76. PMID 3807028 DOI: 10.3143/GERIATRICS.23.469 |
0.01 |
|
| Hide low-probability matches. |